The epidemiology of Candida infections has changed in recent years. Although Candida
albicans is still the main cause of invasive candidiasis in most clinical settings, a substantial …

The number of immunosuppressive patients has increased significantly in recent years.
These patients are at risk for opportunistic infections, especially fungal infections …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Clin Microbiol Infect 2012; 18 (Suppl. 7): 19–37 Abstract This part of the EFISG guidelines
focuses on non‐neutropenic adult patients. Only a few of the numerous recommendations …

Abstract (See the Editorial Commentary by Clancy and Nguyen, on pages 1123–5.)
Background. Invasive candidiasis (IC) is an important healthcare-related infection, with …

Every year, Candida, Aspergillus, Cryptococcus and Pneumocystis infect an estimated two
million individuals worldwide. Most are immunocompromised or critically ill. Candida is the …

With increasing numbers of immune-compromised patients with malignancy, hematologic
disease, and HIV, as well as those receiving immunosupressive drug regimens for the …

The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …

Purpose To analyze trends in incidence and mortality of candidemia in intensive care units
(ICUs) vs. non-ICU hospitalized patients and to determine risk factors for infection by specific …

This analysis describes the epidemiology and outcomes of candidemia in patients enrolled
in the Prospective Antifungal Therapy Alliance (PATH Alliance®) registry from 2004 to 2008 …